EFFECT OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING ILDS AND PRESERVED LUNG FUNCTION AT BASELINE: FURTHER ANALYSES OF THE INBUILD TRIAL
- Resource Type
- Abstract
- Source
- In
Chest October 2020 158(4) Supplement:A1051-A1052 - Subject
- Language
- ISSN
- 0012-3692